[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
January 3, 2001

Devices for In-Stent Restenosis

Author Affiliations

Not Available

Not Available

JAMA. 2001;285(1):34. doi:10.1001/jama.285.1.34

The FDA has approved two new devices for delivery of radiation to treat in-stent tissue growth following restoration of blood supply to a blocked coronary artery. Both brachytherapy systems are designed to be placed at the site of the in-stent restenosis following opening of the blockage with a balloon, atherectomy, or excimer laser catheter. The radiation treatment is intended to prevent exaggerated healing response at the site and recurrence of significant blockage within the stent.

First Page Preview View Large
First page PDF preview
First page PDF preview